Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51

Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis in Asia with a case fatality rate up to 35% and long-term sequelae up to 75%. This active-controlled, randomized, multi-centre, observer-blind, phase III trial investigated the neutralising antibody response to the new Japa...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 26; no. 48; pp. 6151 - 6156
Main Authors Schuller, Elisabeth, Klade, Christoph S., Heinz, Franz X., Kollaritsch, Herwig, Rendi-Wagner, Pamela, Jilma, Bernd, Tauber, Erich
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 11.11.2008
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…